Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of High Dose Methotrexate in Pediatric ALL
NCT02011022Completed
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- May 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of methotrexate in acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL) (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Elimination Delay at 3 days. Started May 2009; status: completed.
02
Drugs
methotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02011022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02011022.